Key result
Telemonitoring in heart failure management presents conflicting evidence regarding its efficacy, likely due to heterogeneity in devices, patient populations, and healthcare systems.
Why the study?
Despite growing telemonitoring options to prevent worsening heart failure, reaching positive outcomes faces challenges due to conflicting trial evidence, device heterogeneity, patient differences, and healthcare system variabilities.
Telemonitoring in heart failure faces challenges in reaching positive outcomes due to heterogeneity in devices, populations, and healthcare systems.
Caution against routine HF telemonitoring adoption; leaves open identification of effective device-population-system combinations.
Telemonitoring (TM) aims to predict and prevent worsening heart failure (HF) episodes and improve self-care, patient education, treatment adherence and survival. There is a growing number of TM options for patients with HF, but there are numerous challenges in reaching positive outcomes. Conflicting evidence from clinical trials may be the result of the enormous heterogeneity of TM devices tested, differences in selected patient populations and variabilities between healthcare systems. This article covers some basic concepts of TM, looking at the recent advances in the most frequently used types of TM and the evidence to support its use in the care of people with HF.
No takes yet. Share an insight, caveat, or question.
Planinc et al. (2020) conducted a review in Heart failure. Telemonitoring was evaluated. Telemonitoring in heart failure management presents conflicting evidence regarding its efficacy, likely due to heterogeneity in devices, patient populations, and healthcare systems.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: